# P120012: Abbott Realtime HCV Genotype II, Abbott Realtime HCV Genotype II Control Kit, Uracil-N-Glycosylase (Ung)

- Pathway: PMA
- Applicant: Abbott Molecular
- Decided: Jun 20, 2013 after 343 days
- Product code: OBF (Assay, Genotyping, Hepatitis C Virus)
- Device class: 2
- Regulation: 21 CFR 866.3170
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
No later device cites it as a predicate yet.
0 of 1 device in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. PMA decisions do not claim a predicate device.

Source page: https://510kreport.com/device/P120012
Methodology: https://510kreport.com/methodology